Sjogren’s Statistics

The vast majority of people with Sjogren’s syndrome are women, and it generally appears in their 40s. The female-to-male ratio of Sjogren’s syndrome is 9:1. Sjogren’s syndrome can affect individuals of any age but is most common in elderly people

Sjogren’s syndrome can affect all age groups, and it can occur in all races.

You may be at higher risk of developing Sjogren’s syndrome if other members of your family had this condition.

There is no way to prevent Sjogren’s syndrome or reduce your risk of developing the condition.

Lymphoma in Sjogren’s Syndrome

People with Sjogren’s syndrome have a higher rate of non-Hodgkin lymphoma compared to both patients with other autoimmune diseases and healthy people. About 5% of patients with Sjogren’s syndrome will develop some form of lymphoid malignancy. Patients with severe cases are much more likely to develop lymphomas than patients with mild or moderate cases. The most common lymphomas are salivary B cell lymphomas and diffuse large B-cell lymphoma.

References

1. Kaneko Y. [Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: VII. Sjogren’s Syndrome]. Nihon Naika Gakkai Zasshi. 2015 Oct;104(10):2149-56. [PubMed]

2. Brito-Zerón P, Retamozo S, Ramos-Casals M. Phenotyping Sjogren’s syndrome: towards a personalised management of the disease. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):198-209. [PubMed]

3. Argyropoulou OD, Valentini E, Ferro F, Leone MC, Cafaro G, Bartoloni E, Baldini C. One year in review 2018: Sjogren’s syndrome. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):14-26. [PubMed]

4. Baer AN, Akpek EK, Alevizos I., 18-21 April 2018, Washington, DC, USA. 14th International Symposium on Sjogren’s Syndrome. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):241-255. [PubMed]

5. Kroese FGM, Haacke EA, Bombardieri M. The role of salivary gland histopathology in primary Sjogren’s syndrome: promises and pitfalls. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):222-233. [PubMed]

6. Kiadaliri AA, Mohammad AJ, Englund M. Hospitalizations due to systemic connective tissue diseases: Secular trends and regional disparities in Sweden, 1998-2016. Int J Rheum Dis. 2018 Nov;21(11):1900-1906. [PubMed]

7. Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018 Mar;47(2):141-154. [PubMed]

8. Bunya VY, Fernandez KB, Ying GS, Massaro-Giordano M, Macchi I, Sulewski ME, Hammersmith KM, Nagra PK, Rapuano CJ, Orlin SE. Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren’s Syndrome. Eye Contact Lens. 2018 Nov;44 Suppl 2(Suppl 2):S196-S201. [PMC free article] [PubMed]

9. Tzioufas AG, Goules AV. Limited efficacy of targeted treatments in Sjogren’s syndrome: why? Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):27-28. [PubMed]

10. De Vita S, Gandolfo S, Zandonella Callegher S, Zabotti A, Quartuccio L. The evaluation of disease activity in Sjogren’s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):150-156. [PubMed]

11. Martel A, Coiffier G, Bleuzen A, Goasguen J, de Bandt M, Deligny C, Magnant J, Ferreira N, Diot E, Perdriger A, Maillot F. What is the best salivary gland ultrasonography scoring methods for the diagnosis of primary or secondary Sjogren’s syndromes? Joint Bone Spine. 2019 Mar;86(2):211-217. [PubMed]

12. Baer AN, Walitt B. Update on Sjogren Syndrome and Other Causes of Sicca in Older Adults. Rheum Dis Clin North Am. 2018 Aug;44(3):419-436. [PMC free article] [PubMed]

13. Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I, Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nishiyama S, Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H. Clinical practice guideline for Sjögren’s syndrome 2017. Mod Rheumatol. 2018 May;28(3):383-408. [PubMed]

 

14. Seror R, Mariette X. Guidelines for treatment of primary Sjögren’s syndrome: a first useful stone but still much to do. Rheumatology (Oxford). 2017 Oct 01;56(10):1641-1642. [PubMed]

15. Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng WF, Fisher BA, Bombardieri M, Astorri E, Empson B, Larkin G, Crampton B, Bowman SJ., British Society for Rheumatology Standards, Guideline and Audit Working Group. The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome. Rheumatology (Oxford). 2017 Oct 01;56(10):e24-e48. [PubMed]

References For Renal Damage

1. Wen W, Liu Y, Zhao C, Sun X, Zhang C, Li Z. Clinical
and serologic features of primary Sjögren’s syndrome
concomitant with autoimmune hemolytic anemia: A large-
scale cross-sectional study. Clin Rheumatol. 2015;34:1877-
84. doi: 10.1007/s10067-015-3081-0
2. Ni P, Men R, Shen M, Wang T, Huang C, Fan X, et al.
Concomitant Sjögren’s syndrome was not associated
with a poorer response or outcomes in ursodeoxycholic
acid-treated patients with primary biliary cholangitis.
Can J Gastroenterol Hepatol. 2019;2019:7396870. doi:
10.1155/2019/7396870
3. Nikitakis N, Papaioannou W, Sakkas L, Kousvelari E. The
autoimmunity–oral microbiome connection. Oral Dis.
2017;23:828-39. doi: 10.1111/odi.12589
4. Kabasakal Y, Kitapcioglu G, Turk T, Öder G, Durusoy R,
Mete N, et al. The prevalence of Sjögren’s syndrome in
adult women. Scand J Rheumatol. 2006;35:379-83. doi:
10.1080/03009740600759704.
5. Loustaud-Ratti V, Riche A, Liozon E, Labrousse F, Soria P,
Rogez S, et al. Prevalence and characteristics of Sjögren’s
syndrome or Sicca syndrome in chronic hepatitis C virus
infection: a prospective study. J Rheumatol. 2001;28:2245-
51.
6. Haga H, Naderi Y, Moreno A, Peen E. A study of the
prevalence of sicca symptoms and secondary S jögren’s
syndrome in patients with rheumatoid arthritis, and
its association to disease activity and treatment profile.
Int J Rheum Dis. 2012;15:284-8. doi: 10.1111/j.1756-
185X.2012.01717.x
7. Can G, Sarıoğlu S, Birlik A, Kenar G, Soysal Ö, Solmaz
D, et al. The prevalence of Sjögren’s syndrome and sicca
symptoms in patients with systemicsclerosis and alpha-
smooth muscle actin expression in biopsy specimens from
minorsalivary glands. Turk J Med Sci. 2021;51:1875-82. doi:
10.3906/sag-2012-25
8. Westhoff G, Dörner T, Zink A. Fatigue and depression
predict physician visits and work disability in women with
primary Sjögren’s syndrome: results from a cohort study.
Rheumatology (Oxford). 2012;51:262-9. doi: 10.1093/
rheumatology/ker208
9. Zhang Q, Wang X, Chen H, Shen B. Sjögren’s syndrome
is associated with negatively variable impacts on domains
of health-related quality of life: evidence from Short Form
36 questionnaire and a meta-analysis. Patient Prefer
Adherence. 2017;11:905-11. doi: 10.2147/PPA.S132751
10. Voulgarelis M, Dafni U, Isenberg D, Moutsopoulos H. Malig-
nant lymphoma in primary Sjögren’s syndrome: a multicenter,
retrospective, clinical study by the European Concerted Ac-
tion on Sjögren’s Syndrome. Arthritis Rheum. 1999;42:1765-
72. doi: 10.1002/1529-0131(199908)42:8<1765::AID-
ANR28>3.0.CO;2-V
11. Alani H, Henty J, Thompson N, Jury E, Ciurtin C.
Systematic review and meta-analysis of the epidemiology
of polyautoimmunity in Sjögren’s syndrome (secondary
Journal of Renal Injury Prevention, Volume 14, Issue 1, March 2025https://journalrip.com 9Sjogren’s syndrome
Sjögren’s syndrome) focusing on autoimmune rheumatic
diseases. Scand J Rheumatol. 2018;47:141-54. doi:
10.1080/03009742.2017.1324909

TheraLife Sjogrens Syndrome Treatment Starter Kit